Zobrazeno 1 - 2
of 2
pro vyhledávání: '"James A. Schraidt"'
Autor:
Caroline M. Moore, Lauren E. King, John Withington, Mahul B. Amin, Mark Andrews, Erik Briers, Ronald C. Chen, Francis I. Chinegwundoh, Matthew R. Cooperberg, Jane Crowe, Antonio Finelli, Margaret I. Fitch, Mark Frydenberg, Francesco Giganti, Masoom A. Haider, John Freeman, Joseph Gallo, Stephen Gibbs, Anthony Henry, Nicholas James, Netty Kinsella, Thomas B.L. Lam, Mark Lichty, Stacy Loeb, Brandon A. Mahal, Ken Mastris, Anita V. Mitra, Samuel W.D. Merriel, Theodorus van der Kwast, Mieke Van Hemelrijck, Nynikka R. Palmer, Catherine C. Paterson, Monique J. Roobol, Phillip Segal, James A. Schraidt, Camille E. Short, M. Minhaj Siddiqui, Clare M.C. Tempany, Arnaud Villers, Howard Wolinsky, Steven MacLennan
Publikováno v:
Moore, C M, King, L, Withington, J, Amin, M, Andrews, M, Briers, E, Chen, R, Chinegwundoh, F, Matthew, C, Crowe, J, Finelli, A, Fitch, M, Frydenberg, M, Giganti, F, Haider, M, Freeman, J, Gallo, J, Gibbs, S, Henry, A, James, N, Kinsella, N, Lam, T, Lichty, M, Loeb, S, Mahal, B, Mastris, K, Mitra, A, Merriel, S, van der Kwast, T, van Hemelrijck, M, Palmer, N, Paterson, C, Roobol, M, Segal, P, Schraidt, J, Short, C, Siddiqu, M M, Tempany, C, Villiers, A, Wolinsky, H & MacLennan, S 2023, ' Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer—A Report of a Movember International Consensus Meeting ', European Urology Oncology . https://doi.org/10.1016/j.euo.2023.01.003
European urology oncology, 6(2), 160-182. Elsevier
European urology oncology, 6(2), 160-182. Elsevier
BACKGROUND: Active surveillance (AS) is recommended for low-risk and some intermediate-risk prostate cancer. Uptake and practice of AS vary significantly across different settings, as does the experience of surveillance-from which tests are offered,
Autor:
Yaw A. Nyame, James A. Schraidt, Marty Chakoian, Merel Grey Nissenberg, Amy N. Luckenbaugh, Thomas N. Kirk, Erika M. Wolff, Heather H. Cheng, Angela B. Smith, John L. Gore
Publikováno v:
The Journal of urology. 208(2)
Research priorities are often set by expert clinicians and researchers. We sought to apply an established process in patient-centered research to engage survivors and their caregivers in prioritizing research topics in prostate cancer.A prostate canc